Time BioVentures
Our Team Our Portfolio News & Views Contact
Our TeamOur PortfolioNews & ViewsContact
Time BioVentures
Brightside Health
Brightside Health

Comprehensive mental health platform revolutionizing virtual care.

Read More
Care DeliverySquareflairApril 1, 2024Care Delivery
Aquea Health
Aquea Health

A minimally invasive first-principle approach for solving glaucoma.

Read More
DevicesSquareflairApril 1, 2024Devices
Conceivable Life Sciences
Conceivable Life Sciences

Automating NextGen Fertility Treatment

Read More
Care DeliverySquareflairNovember 28, 2023Care Delivery
Commons Clinic
Commons Clinic

Multi-specialty clinics network transforming value-based care.

Read More
Care DeliverySquareflairOctober 16, 2023Care Delivery
CS Genetics
CS Genetics

Democratizing single-cell sequencing.

Read More
ToolsSquareflairOctober 12, 2022Research Tools
Phantom Neuro
Phantom Neuro

Enabling lifelike control of prosthetics

Read More
DevicesSquareflairOctober 12, 2022Devices
BillionToOne
BillionToOne

Ultra-sensitive, low-cost prenatal testing.

Read More
DxSquareflairJune 5, 2022Diagnostics
NanoMosaic
NanoMosaic

Unlocking the human proteome.

Read More
ToolsSquareflairJune 5, 2022Research Tools
DeepSight
DeepSight

A breakthrough in ultrasound diagnostics.

Read More
DxSquareflairMay 6, 2022Diagnostics, Devices
Kling Biotherapeutics
Kling Biotherapeutics

Clinical-stage antibody therapeutics derived from the immune systems of remarkable patients.

Read More
TxSquareflairMay 6, 2022Therapeutics
Iterative Health
Iterative Health

Revolutionizing gastrointestinal medicine with AI.

Read More
Care DeliverySquareflairMay 6, 2022Care Delivery
Neuralink
Neuralink

Brain-machine interfaces to serve severely-disabled patients.

Read More
DevicesSquareflairMay 5, 2022Devices
Stealth Co (Therapeutics)
Stealth Co (Therapeutics)

Stealth-stage therapeutics company developing a novel class of molecules utilizing a groundbreaking discovery platform.

Read More
TxSquareflairMay 2, 2022Therapeutics
TIME BioVentures Logo

Our Team Our Portfolio News & Views Contact

© 2022 TIME BioVentures